Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib

Purpose: The sensitivity of advanced hepatocellular carcinoma (HCC) to Sorafenib is low. The purpose of this study was to investigate the effects of cyclin-dependent kinase inhibitor 2B (CDKN2B) gene on the prognosis of HCC and the sensitivity of HCC cells to Sorafenib. Patients and methods: Strepta...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Xie, Zeng, Lixian, Yan, Feifei, He, Mengxue, Wu, Xiuqiong, Zheng, Dayong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607202/
https://www.ncbi.nlm.nih.gov/pubmed/31388306
http://dx.doi.org/10.2147/OTT.S196607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607202/
https://www.ncbi.nlm.nih.gov/pubmed/31388306
http://dx.doi.org/10.2147/OTT.S196607

Ejemplares similares